Testing a new insulin approach for kidney disease and diabetes
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new approach to help your body use insulin better, which may improve blood sugar control and slow down kidney disease. It is for people with advanced chronic kidney disease and type 2 diabetes who are not yet on dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic kidney disease (stage 3b, 4, or 5) and have had type 2 diabetes for at least 6 months.
- You are not currently on dialysis.
- You haven't had cancer treatment (except for minor skin cancers) in the last 2 years.
- You are not pregnant, planning to become pregnant, or nursing during the study.
- You have not used non-prescription opioids or psychoactive drugs in the last year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special type of insulin delivery system (closed-loop) can help people with type 2 diabetes and chronic kidney disease. You'll wear a continuous glucose monitor and insulin pump, and researchers will track how your kidneys respond over time.
This trial tests an automated insulin delivery system (Omnipod 5) for people with type 2 diabetes who are on hemodialysis. The goal is to see if it helps control blood sugar safely.
This study looks at how different levels of kidney function affect the amount of a medication in the body. It may help doctors decide on the right dose for people with kidney problems.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study tests a new drug called IGT-303 for people with chronic kidney disease caused by type 2 diabetes. It aims to see if the drug is safe and can help protect kidney function.
This trial tests a new system to manage diabetic kidney disease across all stages. It is for people with type 2 diabetes who either have no kidney damage or have kidney damage confirmed by a biopsy.
Hear when a new Chronic Kidney Disease (Stages 4 and 5) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.